These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
446 related articles for article (PubMed ID: 33087823)
21. Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke. Ismael S; Zhao L; Nasoohi S; Ishrat T Sci Rep; 2018 Apr; 8(1):5971. PubMed ID: 29654318 [TBL] [Abstract][Full Text] [Related]
22. MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition. Vande Walle L; Stowe IB; Šácha P; Lee BL; Demon D; Fossoul A; Van Hauwermeiren F; Saavedra PHV; Šimon P; Šubrt V; Kostka L; Stivala CE; Pham VC; Staben ST; Yamazoe S; Konvalinka J; Kayagaki N; Lamkanfi M PLoS Biol; 2019 Sep; 17(9):e3000354. PubMed ID: 31525186 [TBL] [Abstract][Full Text] [Related]
23. Pharmacological inhibition of the NLRP3 inflammasome as a potential target for cancer-induced bone pain. Chen SP; Zhou YQ; Wang XM; Sun J; Cao F; HaiSam S; Ye DW; Tian YK Pharmacol Res; 2019 Sep; 147():104339. PubMed ID: 31276771 [TBL] [Abstract][Full Text] [Related]
24. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Coll RC; Robertson AA; Chae JJ; Higgins SC; Muñoz-Planillo R; Inserra MC; Vetter I; Dungan LS; Monks BG; Stutz A; Croker DE; Butler MS; Haneklaus M; Sutton CE; Núñez G; Latz E; Kastner DL; Mills KH; Masters SL; Schroder K; Cooper MA; O'Neill LA Nat Med; 2015 Mar; 21(3):248-55. PubMed ID: 25686105 [TBL] [Abstract][Full Text] [Related]
25. The covalent NLRP3-inflammasome inhibitor Oridonin relieves myocardial infarction induced myocardial fibrosis and cardiac remodeling in mice. Gao RF; Li X; Xiang HY; Yang H; Lv CY; Sun XL; Chen HZ; Gao Y; Yang JS; Luo W; Yang YQ; Tang YH Int Immunopharmacol; 2021 Jan; 90():107133. PubMed ID: 33168408 [TBL] [Abstract][Full Text] [Related]
26. MCC950 Inhibits NLRP3 Inflammasome and Alleviates Axonal Injures in Early Stages of Diffuse Axonal Injury in Rats. Zhao J; Guo X; Wang B; Yang Z; Huang T; Guo D; Zhang M; Song J Neurochem Res; 2020 Sep; 45(9):2020-2031. PubMed ID: 32474832 [TBL] [Abstract][Full Text] [Related]
27. Activation of NLRP3 inflammasome up-regulates TREM-1 expression in murine macrophages via HMGB1 and IL-18. Zhong WJ; Duan JX; Liu T; Yang HH; Guan XX; Zhang CY; Yang JT; Xiong JB; Zhou Y; Guan CX; Li Q Int Immunopharmacol; 2020 Dec; 89(Pt A):107045. PubMed ID: 33045564 [TBL] [Abstract][Full Text] [Related]
28. Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension. Krishnan SM; Ling YH; Huuskes BM; Ferens DM; Saini N; Chan CT; Diep H; Kett MM; Samuel CS; Kemp-Harper BK; Robertson AAB; Cooper MA; Peter K; Latz E; Mansell AS; Sobey CG; Drummond GR; Vinh A Cardiovasc Res; 2019 Mar; 115(4):776-787. PubMed ID: 30357309 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of NLRP3 Inflammasome Prevents LPS-Induced Inflammatory Hyperalgesia in Mice: Contribution of NF-κB, Caspase-1/11, ASC, NOX, and NOS Isoforms. Dolunay A; Senol SP; Temiz-Resitoglu M; Guden DS; Sari AN; Sahan-Firat S; Tunctan B Inflammation; 2017 Apr; 40(2):366-386. PubMed ID: 27924425 [TBL] [Abstract][Full Text] [Related]
30. Role of the NLRP3 inflammasome in a model of acute burn-induced pain. Deuis JR; Yin K; Cooper MA; Schroder K; Vetter I Burns; 2017 Mar; 43(2):304-309. PubMed ID: 28040362 [TBL] [Abstract][Full Text] [Related]
31. A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson's disease. Huang S; Chen Z; Fan B; Chen Y; Zhou L; Jiang B; Long H; Zhong W; Li X; Li Y J Neuroimmunol; 2021 May; 354():577543. PubMed ID: 33714750 [TBL] [Abstract][Full Text] [Related]
32. MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition. Coll RC; Hill JR; Day CJ; Zamoshnikova A; Boucher D; Massey NL; Chitty JL; Fraser JA; Jennings MP; Robertson AAB; Schroder K Nat Chem Biol; 2019 Jun; 15(6):556-559. PubMed ID: 31086327 [TBL] [Abstract][Full Text] [Related]
33. MCC950 in the treatment of NLRP3-mediated inflammatory diseases: Latest evidence and therapeutic outcomes. Bakhshi S; Shamsi S Int Immunopharmacol; 2022 May; 106():108595. PubMed ID: 35124417 [TBL] [Abstract][Full Text] [Related]
34. An NLRP3-specific inflammasome inhibitor attenuates crystal-induced kidney fibrosis in mice. Ludwig-Portugall I; Bartok E; Dhana E; Evers BD; Primiano MJ; Hall JP; Franklin BS; Knolle PA; Hornung V; Hartmann G; Boor P; Latz E; Kurts C Kidney Int; 2016 Sep; 90(3):525-39. PubMed ID: 27262364 [TBL] [Abstract][Full Text] [Related]
35. MCC950, a selective NLPR3 inflammasome inhibitor, improves neurologic function and survival after cardiac arrest and resuscitation. Jiang M; Li R; Lyu J; Li X; Wang W; Wang Z; Sheng H; Zhang W; Karhausen J; Yang W J Neuroinflammation; 2020 Aug; 17(1):256. PubMed ID: 32867797 [TBL] [Abstract][Full Text] [Related]
36. Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome. Sano S; Oshima K; Wang Y; MacLauchlan S; Katanasaka Y; Sano M; Zuriaga MA; Yoshiyama M; Goukassian D; Cooper MA; Fuster JJ; Walsh K J Am Coll Cardiol; 2018 Feb; 71(8):875-886. PubMed ID: 29471939 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of NLRP3 inflammasome alleviates cognitive deficits in a mouse model of anti-NMDAR encephalitis induced by active immunization. Yang X; Sun A; Kong L; Yang X; Zhao X; Wang S Int Immunopharmacol; 2024 Aug; 137():112374. PubMed ID: 38851162 [TBL] [Abstract][Full Text] [Related]
38. NLRP3 Inflammasome Inhibition by MCC950 in Aged Mice Improves Health via Enhanced Autophagy and PPARα Activity. Marín-Aguilar F; Castejón-Vega B; Alcocer-Gómez E; Lendines-Cordero D; Cooper MA; de la Cruz P; Andújar-Pulido E; Pérez-Alegre M; Muntané J; Pérez-Pulido AJ; Ryffel B; Robertson AAB; Ruiz-Cabello J; Bullón P; Cordero MD J Gerontol A Biol Sci Med Sci; 2020 Jul; 75(8):1457-1464. PubMed ID: 31603987 [TBL] [Abstract][Full Text] [Related]
39. Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice. Dempsey C; Rubio Araiz A; Bryson KJ; Finucane O; Larkin C; Mills EL; Robertson AAB; Cooper MA; O'Neill LAJ; Lynch MA Brain Behav Immun; 2017 Mar; 61():306-316. PubMed ID: 28003153 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of the NLRP3 inflammasome reduces brain edema and regulates the distribution of aquaporin-4 after cerebral ischaemia-reperfusion. Wang H; Chen H; Jin J; Liu Q; Zhong D; Li G Life Sci; 2020 Jun; 251():117638. PubMed ID: 32251636 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]